Published in Br J Pharmacol on November 01, 1993
Role of endothelin-1 in lung disease. Respir Res (2001) 1.36
Bradykinin and changes in microvascular permeability in the hamster cheek pouch: role of nitric oxide. Br J Pharmacol (1996) 0.89
Nitric oxide as a mediator of gastrointestinal mucosal injury?-Say it ain't so. Mediators Inflamm (1995) 0.88
Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2. Br J Pharmacol (1994) 0.88
Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat. Br J Pharmacol (1994) 0.87
Enhancing and limiting endothelin-1 signaling with a cell-penetrating peptide mimicking the third intracellular loop of the ETB receptor. Chem Biol Drug Des (2012) 0.85
Activation of neuronal endothelin B receptors mediates pressor response through alpha-1 adrenergic receptors. Physiol Rep (2017) 0.75
Endogenous nitric oxide in the maintenance of rat microvascular integrity against widespread plasma leakage following abdominal laparotomy. Br J Pharmacol (1999) 0.75
Endothelin mediated nitric oxide effects in ischemia--reperfusion associated with pancreas transplantation. Dig Dis Sci (1998) 0.75
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60
Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (1988) 18.41
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A (1987) 14.22
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol (1990) 8.85
Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A (1989) 8.34
Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A (1991) 8.04
L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun (1988) 7.77
L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol (1990) 7.27
Endothelium-derived relaxing and contracting factors. FASEB J (1989) 7.22
The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol (1984) 6.74
Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A (1988) 4.77
Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet (1987) 4.55
Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A (1988) 3.44
Control of regional blood flow by endothelium-derived nitric oxide. Hypertension (1990) 2.93
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest (1990) 2.61
Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol (1989) 2.44
Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci U S A (1988) 2.34
Nitric oxide modulates microvascular permeability. Am J Physiol (1992) 2.21
Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol (1990) 1.94
Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem Biophys Res Commun (1990) 1.94
Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester. Br J Pharmacol (1990) 1.77
L-arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. Biochem Biophys Res Commun (1989) 1.76
Speculations on neurogenic pulmonary edema (NPE). Am Rev Respir Dis (1976) 1.72
Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol (1988) 1.50
Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol (1990) 1.37
Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br J Pharmacol (1991) 1.27
NG-monomethyl-L-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats. Eur J Pharmacol (1989) 1.16
Physiological and pharmacological evidence for the regulation of permeability. Fed Proc (1986) 1.13
Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J Hypertens (1990) 1.13
Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release. J Pharmacol Exp Ther (1991) 1.08
Increase in microvascular permeability induced by enzymatically generated free radicals. I. In vivo study. Microvasc Res (1981) 1.05
Haemodynamic changes and acetylcholine-induced hypotensive responses after NG-nitro-L-arginine methyl ester in rats and cats. Br J Pharmacol (1991) 0.99
Effect of endothelin on renal function in rats. Eur J Pharmacol (1989) 0.98
Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor. Eur J Pharmacol (1992) 0.97
Renal ischemia and reperfusion impair endothelium-dependent vascular relaxation. Am J Physiol (1989) 0.96
Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem Biophys Res Commun (1990) 0.94
Vascular responses to leukotriene B4, C4 and D4 following FPL 55712, indomethacin, saralasin, phentolamine and verapamil in the conscious rat. Br J Pharmacol (1987) 0.93
The role of nitric oxide in the regional vasodilator effects of endothelin-1 in the rat. Br J Pharmacol (1992) 0.92
Effects of vascular pressure on the pulmonary microvasculature in isolated dog lungs. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.91
On the existence of stretchable pores in the exchange vessels of the isolated rabbit lung preparation. Lymphology (1979) 0.90
Nitric oxide modulates vascular permeability in the rat coronary circulation. Br J Pharmacol (1993) 0.90
Effect of endothelin on plasma volume and albumin escape. Circ Res (1992) 0.83
Effect of sympathetic nerve stimulation on lung vascular permeability in the rat. Am Rev Respir Dis (1992) 0.79
Adrenoceptor control of lung fluid and protein exchange. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.77
Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell (1999) 3.84
Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature (1986) 3.73
Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev (2000) 3.24
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
The long QT syndrome in children. An international study of 287 patients. Circulation (1993) 2.31
Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab (1997) 2.30
Predictive factors for spontaneous closure of atrial septal defects diagnosed in the first 3 months of life. J Am Coll Cardiol (1993) 2.27
Structure and in vitro transcription of a glycine tRNA gene from Bombyx mori. EMBO J (1984) 2.27
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest (1996) 2.20
Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine. Br J Pharmacol (1978) 2.20
Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci (1999) 2.13
Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation. Kidney Int (2000) 1.99
Can ethnic differences in men's preferences for women's body shapes contribute to ethnic differences in female adiposity? Obes Res (1993) 1.97
Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils. Circulation (1997) 1.86
Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation. Am J Transplant (2007) 1.76
[Single-use laryngoscope blade assessment]. Ann Fr Anesth Reanim (2004) 1.65
Interaction between the release of SRS-A and of prostaglandins [proceedings]. Br J Pharmacol (1976) 1.63
hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther (1990) 1.60
Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches. Pharmacol Res (2010) 1.50
Slow-reacting substance of anaphylaxis: purification and characterisation. FEBS Lett (1978) 1.48
Bevacizumab and irinotecan for recurrent oligodendroglial tumors. Neurology (2009) 1.48
Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther (1989) 1.42
Calcitriol and calcium carbonate therapy in early chronic renal failure. Nephrol Dial Transplant (1995) 1.40
Postoperative evaluation after end-to-end subclavian-left coronary artery anastomosis in anomalous left coronary artery. J Thorac Cardiovasc Surg (1990) 1.39
[Factors in the progression of renal insufficiency during the 2 years preceding the use of dialysis]. Nephrologie (1999) 1.39
Transformation of arachidonic acid in leukocytes. Isolation and structural analysis of a novel dihydroxy derivative. Prostaglandins Med (1981) 1.36
Growth regulatory properties of endothelins. Peptides (1993) 1.35
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol (1992) 1.33
Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int (2001) 1.31
Monoclonal antibodies to rabbit progesterone receptor: crossreaction with other mammalian progesterone receptors. Proc Natl Acad Sci U S A (1983) 1.29
Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br J Pharmacol (1991) 1.27
Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int (1991) 1.27
Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2011) 1.27
Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest (1993) 1.25
Adaptation of iso-tRNA concentration to mRNA codon frequency in the eukaryote cell. Biochimie (1979) 1.25
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ (1994) 1.24
Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. J Appl Physiol (1985) (1996) 1.21
Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis. Diabetologia (2006) 1.19
One-step immunoaffinity purification of active progesterone receptor. Further evidence in favor of the existence of a single steroid binding subunit. Biochemistry (1985) 1.19
Synthesis, biological activity and conformational analysis of cyclic GRF analogs. Int J Pept Protein Res (1988) 1.18
Stable multicopy vectors for high-level secretion of recombinant human serum albumin by Kluyveromyces yeasts. Biotechnology (N Y) (1991) 1.18
The release of prostaglandins and thromboxanes from guinea-pig lung by slow reacting substance of anaphylaxis, and its inhibition. Br J Pharmacol (1978) 1.18
The action of leukotriene B4 (LTB4) on the lung. Prostaglandins Med (1980) 1.17
Behaviours in trematode cercariae that enhance parasite transmission: patterns and processes. Parasitology (1994) 1.16
PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur J Neurosci (2002) 1.16
The S. Cerevisiae HAP complex, a key regulator of mitochondrial function, coordinates nuclear and mitochondrial gene expression. Comp Funct Genomics (2003) 1.16
Validation of the EORTC QLQ-SAT32 cancer inpatient satisfaction questionnaire by self- versus interview-assessment comparison. Patient Educ Couns (2004) 1.14
A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes. Mol Psychiatry (2001) 1.13
Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br J Pharmacol (1991) 1.13
Lack of histological evidence of vitamin D abnormality in the bones of anephric patients. Clin Sci (1973) 1.11
High-level secretion of correctly processed recombinant human interleukin-1 beta in Kluyveromyces lactis. Gene (1991) 1.10
Automated on-line extraction and profiling of lipoxygenase products of arachidonic acid by high-performance liquid chromatography. Methods Enzymol (1990) 1.10
Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus. Brain Res (1997) 1.10
Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells. Mol Cell Endocrinol (2001) 1.07
Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci (1993) 1.07
Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc Natl Acad Sci U S A (1999) 1.07
Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience (1997) 1.06
Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction? Stroke (2003) 1.06
Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br J Pharmacol (1999) 1.05
Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis. Artif Organs (1998) 1.04
Production of alginate beads by emulsification/internal gelation. I. Methodology. Appl Microbiol Biotechnol (1992) 1.04
Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart (2003) 1.03
Leukotriene B4 augments human natural cytotoxic cell activity. Biochem Biophys Res Commun (1983) 1.03
Leukotriene B4 induces human suppressor lymphocytes. Biochem Biophys Res Commun (1982) 1.03
[Overdosage of metoclopramide in child. Apropos of 9 clinical cases]. Pediatrie (1970) 1.03
Phospholipase A activity and prostaglandin release from alveolar macrophages exposed to asbestos. Prostaglandins Med (1980) 1.02
Characterization of CGRP1 and CGRP2 receptor subtypes. Ann N Y Acad Sci (1992) 1.02
Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation. J Pharmacol Exp Ther (1992) 1.01
Project Medishare: a volunteer program in international health at the University of Miami. Acad Med (2000) 1.01
Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065. Br J Pharmacol (1994) 1.01
Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2010) 1.01
Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience (1998) 1.01
Leukotriene B4 receptors on guinea pig alveolar eosinophils. J Pharmacol Exp Ther (1991) 1.00
Human cardiovascular dose-response to supplemental oxygen. Acta Physiol (Oxf) (2007) 1.00
Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. J Pharmacol Exp Ther (1991) 1.00
[Collapsing glomerulopathy and cytomegalovirus, what are the links?]. Presse Med (2000) 1.00
[Metoclopramide poisoning in children]. Nouv Presse Med (1972) 0.99
Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5). Can J Physiol Pharmacol (2000) 0.99
Metformin-associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis. Nephrol Dial Transplant (1994) 0.99
Sympathetic innervation of the upper and lower regions of the uterus and cervix in the rat have different origins and routes. J Comp Neurol (1998) 0.99
Permeability of endothelial monolayers to albumin is increased by bradykinin and inhibited by prostaglandins. Am J Physiol Lung Cell Mol Physiol (2001) 0.99
Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat. Br J Pharmacol (1993) 0.98
Effects of C-reactive protein on human neutrophil granulocytes challenged with N-formyl-methionyl-leucyl-phenylalanine and platelet-activating factor. Life Sci (1989) 0.98
Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy. Kidney Int (1992) 0.98
Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment. Intensive Care Med (1991) 0.97
Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor. Eur J Pharmacol (1992) 0.97
Characterization of melanotropin-release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y. Proc Natl Acad Sci U S A (1991) 0.97
Pharmacological activity of leukotrienes A4, B4, C4 and D4 on selected guinea-pig, rat, rabbit and human smooth muscles. Prostaglandins Med (1981) 0.97
[Letter: Neonatal septicemia and meningitis caused by Levinea malonatica]. Nouv Presse Med (1975) 0.97
Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. J Pharmacol Exp Ther (1995) 0.97
From slow reacting substance of anaphylaxis (SRS-A) to leukotriene D4 (LTD4). Int J Immunopharmacol (1980) 0.97
A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet (2000) 0.97
Primary pineal melanoma with leptomeningeal spreading: case report and review of the literature. Clin Neuropathol (2009) 0.96